Urological Research

, Volume 34, Issue 2, pp 151–156 | Cite as

Epidemiological trends in urolithiasis: impact on our health care systems

Article
First Online:
Accepted:

Abstract

The progressive increase of the social cost for treating urolithiasis could be related to an increased incidence of the disease and/or to an increase of costs for diagnosing and treating renal stones. In the course of the last century, the incidence of renal stones has progressively increased in Europe, North America, and other industrialised countries. This has been explained in terms of changing social conditions and the consequent changes in eating habits. In contrast, renal stones were less frequent than in developing countries of the world but in the last 20 years investigators began to report high incidences of upper urinary stone disease also from some areas of the Third World concurring with the changing of economic and social conditions. Each stone episode involves the costs for emergency visits, diagnostic work up, and medical or surgical treatment. Furthermore, we have to consider the costs of follow-up visits and the costs of testing and drugs for stone prevention. In adjunct of direct costs for diagnosis and treatment, we should also take into account the indirect individual and social cost of workdays lost. Finally, we should estimate the costs of complications and outcomes of treatment with particular attention to the costs of chronic renal failure secondary to stone disease. The strategy of treatment of each stone centre involves different costs for the treatment of each single stone episode. On the other hand the choice of treatment can be driven by National Health Systems and insurance companies by their policy of reimbursement for different procedures. The trends of renal stone incidence will have different impact on health care systems in different countries. In Europe and North America, the peak of incidence has been probably reached but the increase of costs for diagnosing and treating each single stone episode will still increase the social cost for managing stone disease. For this reason the actual objective should be to optimise protocols avoiding redundant or expensive diagnostic procedures or inappropriate treatments. In developing countries, the incidence of stone disease is still increasing and it could reach peaks even higher as a consequence of hot climate in some geographical areas. In those countries the demand for treatment of symptomatic stones could dramatically increase involving a huge financial outlay.

Keywords

Urinary calculi Epidemiology Economics Cost benefit 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Clark JY, Thompson I, Optenberg SA (1995) Economic impact of urolithiasis in the United States. J Urol 154:2020–2024CrossRefPubMedGoogle Scholar
  2. 2.
    Shuster J, Scheaffer RL (1984) Economic impact of kidney stones in white male adults. Urology 24:327–331CrossRefPubMedGoogle Scholar
  3. 3.
    Trinchieri A (1996) Epidemiology of urolithiasis. Arch Ital Urol 68:203–250Google Scholar
  4. 4.
    Yelloly J (1830) Sequel to remarks on the tendency to calculous disease. Philos Trans R Soc Lond 120:415–428CrossRefGoogle Scholar
  5. 5.
    Andersen DA (1966). A survey of the incidence of urolithiasis in Norway from 1853 to 1960. J Oslo City Hosp 16:101–147PubMedGoogle Scholar
  6. 6.
    Hedenberg I (1951) Renal and ureteral calculi. Acta Chir Scand 101:17–36PubMedGoogle Scholar
  7. 7.
    Sallinen A (1959) Some aspects of urolithiasis in Finland. Acta Chir Scand 118:479–487Google Scholar
  8. 8.
    Ljunghall S, Lithell H, Skarfors E (1987) Prevalence of renal stones in 60-year old men. A 10-year follow-up of a health survey. Br J Urol 60:10–13PubMedGoogle Scholar
  9. 9.
    Anderson GS (1964) Urinary calculus in an island community. Br J Urol 36:556–557PubMedGoogle Scholar
  10. 10.
    Barker DJP, Donnan SPB (1978) Regional variations in the incidence of upper kidney tract stones in England and Wales. Br Med J 1:67–70PubMedGoogle Scholar
  11. 11.
    Power C, Barker DJP, Blacklock NJ (1987) Incidence of renal stones in 18 British towns. A collaborative study. Br J Urol 59:105–110PubMedGoogle Scholar
  12. 12.
    Blacklock NJ (1969) The pattern of urolithiasis in the Royal Navy. J R Nav Med Serv 51:99–111Google Scholar
  13. 13.
    Scott R, Freeland R, Mowat W, Gardner M, Hawthorne V, Marshall M, Ives JGJ (1977) The prevalence of calcified upper urinary tract stone disease in a random population—Cumbernauld health survey. Br J Urol 49:589–595PubMedGoogle Scholar
  14. 14.
    Scott R (1987) Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. Br J Urol 59:111–117PubMedGoogle Scholar
  15. 15.
    Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R, Sergeant V, Smith A (1983) Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 55:595–598PubMedGoogle Scholar
  16. 16.
    Hesse A, Bach D, Vahlensieck W (1981) Epidemiologic survey on urolithiasis in the German Federal Republic. In: Brockis JG, Finlayson B (eds) Urinary calculus. PSG, Littleton pp 25–33Google Scholar
  17. 17.
    Pavone Macaluso M, Piazza B, Madonia S (1965) Modificazioni di alcuni indici statistici nella urolitiasi in Sicilia Rass. Urol Nefrol 3:17–29Google Scholar
  18. 18.
    Borgno M, Frea B, Tizzani A, Bodo G (1976) Importanza sociale della calcolosi dell’apparato uropoietico. Min Urol 28:129–135Google Scholar
  19. 19.
    Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37:23–25CrossRefPubMedGoogle Scholar
  20. 20.
    Borghi L, Ferretti PP, Elia GF, Amato F, Melloni E, Trapassi MR, Novarini A (1990) Epidemiological study of urinary tract stones in a Northern Italian City. Br J Urol 65:231–235PubMedGoogle Scholar
  21. 21.
    Reis Santos JM (1995) Studies on the prevalence of renal stone disease in Portugal: regional variations. In: Rao PN, Kavanagh JP, Tiselius H-G (eds) Urolithiasis: consensus and controversies. South Manchester University Hospitals, Manchester, p 262Google Scholar
  22. 22.
    Karazanashvili G, Butliashvili N, Chavchanidze D, Managadze LG (1995) Spread of the urinary stone diseases in Georgia and its relationship with exogenic factors of nephrolithiasis. In: Abstracts of the sixth European symposium on urolithiasis, Stockholm, p 40Google Scholar
  23. 23.
    Tucek A, Kalem T, Dekanic D (1995) Incidence and risk factors of stone formation. In: Abstracts of the sixth European symposium on urolithiasis, Stockholm, p 60Google Scholar
  24. 24.
    Boyce WH, Garvey FK, Strawcutter HE (1956) Incidence of urinary calculi among patients in general hospitals, 1948 to 1952. JAMA 161:1437–1442Google Scholar
  25. 25.
    Sierakowski R, Finlayson B, Landes R (1979) Stone incidence as related to water hardness in different geographical regions in the United States. Urol Res 7:157–160CrossRefPubMedGoogle Scholar
  26. 26.
    Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833–838CrossRefPubMedGoogle Scholar
  27. 27.
    Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: a 25-year-study in Rochester, Minnesota. Kidney Int 16:624–631PubMedCrossRefGoogle Scholar
  28. 28.
    Thun MJ, Schober S (1991) Urolithiasis in Tennessee: an occupational window into a regional problem. Am J Public Health 81:587–591PubMedGoogle Scholar
  29. 29.
    Churchill DN, Maloney CM, Bear J, Bryant DG, Fodor G, Gault MH (1980) Urolithiasis—a study of drinking water hardness and genetic factors. J Chron Dis 33:727–731CrossRefPubMedGoogle Scholar
  30. 30.
    Iguchi M, Umekawa T, Katayama Y, Takamura C, Kohri K, Kurita T (1994) An epidemiological study of upper urinary stones in Kaizuka City. In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, pp 457–459Google Scholar
  31. 31.
    Robertson WG, Hughes H (1994) Epidemiology of urinary stone disease in Saudi Arabia. In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, pp 453–455Google Scholar
  32. 32.
    Akinci M, Esen T, Tellaloglu S (1994) Urolithiasis in Turkey: epidemiological features and causal factors of stone formation. In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, p 445Google Scholar
  33. 33.
    Lee YK, Chang LS, Chen WC, Lee MH, Huang JK (1995) The epidemiological studies on the prevalence of urolithiasis of Chinese in Taiwan. In: Abstracts of the sixth European symposium on urolithiasis, Stockholm, p 41Google Scholar
  34. 34.
    Ancao MS, Novoa CG, Coelho STSN, Laranja SM, Sigulem D, Heilberg IP, Schor N (1994) The Brasilian multicentric study of nephrolithiasis (Multilit). In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, p 480Google Scholar
  35. 35.
    Rashid HV, Fatima N, Ahmed S, Shamim AM, Alem MK (1995) Clinical characteristics of renal stone disease in Bangladesh. In: Rao PN, Kavanagh JP, Tiselius H-G (eds) Urolithiasis: consensus and controversies. South Manchester University Hospitals, Manchester, pp 411–413Google Scholar
  36. 36.
    Li J, Kennedy D, Levine M, Kumar A, Mullen J (2001) Absent hematuria and expensive computerized tomography: case characteristics of emergency urolithiasis. J Urol 165:782–784CrossRefPubMedGoogle Scholar
  37. 37.
    Chandoke PS, Honey RJDA, Mardis H, Montanari E, Munch L (2003) Economics. In: Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D (eds) Stone disease—first international consultation on stone disease. Editions 21, ParisGoogle Scholar
  38. 38.
    Chandoke PS, DeAntoni E (1998) Cost-effectiveness analysis: application to endourology. J Endourol 12:485–491PubMedCrossRefGoogle Scholar
  39. 39.
    Eisenberger F, Schmidt A (1993) ESWL and the future of stone management. World J Urol 11:2–6CrossRefPubMedGoogle Scholar
  40. 40.
    Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50:1706–1712PubMedCrossRefGoogle Scholar
  41. 41.
    Pisani E, Trinchieri A, Mandressi A, Luongo P, Zaatar A, Longo G (1988) New guidelines for the prevention of renal stone recurrence. In: Giuliani L, Puppo P (eds) Controversies on the management of urinary stones international course, Genoa 1987. Karger, Basel, pp 213–218Google Scholar
  42. 42.
    Tiselius HG (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM (eds) Urolithiasis 2000: proceedings of the 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 349–355Google Scholar
  43. 43.
    Strohmaier WL (2000): Economic aspects of urolithiasis and metaphylaxis in Germany. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM (eds) Urolithiasis 2000: proceedings 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 406–409Google Scholar
  44. 44.
    Robertson WG (1998) Medical management of urinary stone disease. EBU Update Ser 7:139–144Google Scholar
  45. 45.
    Ahlmen J (1975) Incidence of chronic renal insufficiency in adults during 1966–1971 in Gothenburg. Acta Med Scand Suppl 582:3Google Scholar
  46. 46.
    Mebel M, Brien G, Bick C, Gremske D, Fahlenkamp D, Eger E (1982) Results of surgical and conservative therapy on patients with nephrolithiasis and chronic renal insufficiency. Eur Urol 8:150PubMedGoogle Scholar
  47. 47.
    Holmgren K, Danielson BG, Fellstrom B (1987): Infection-induced urinary calculi and renal failure. Scand J Urol Nephrol 21:219PubMedCrossRefGoogle Scholar
  48. 48.
    Blandy JP, Singh M (1976) The case for a more aggressive approach to staghorn stones. J Urol 115:505PubMedGoogle Scholar
  49. 49.
    Rous SN, Turner WR (1977) Retrospective study of 95 patients with staghorn calculus disease. J Urol 118:902PubMedGoogle Scholar
  50. 50.
    Sitprija V (2003) Nephrology in South East Asia: fact and concept. Kidney Int Suppl 83:S128–S130CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Urology UnitA. Manzoni HospitalLeccoItaly

Personalised recommendations